Aqur Biosciences Reinvents Its Look with New Logo Design

Aqur Biosciences (“Aqur”), a bioscience company focused on developing advanced cardiovascular therapies, has announced the launch of its new brand identity.

The rebrand introduces a revamped logo, a redesigned website, and an updated visual identity that the company says reflects its “mission to deliver scientifically driven, patient-centric solutions to combat cardiovascular disease.”

“This rebranding marks a pivotal moment in our journey,” comments Dr. Michael Fole, MD, CEO of Aqur. “As we advance our cholesterol-lowering therapy into the next phase of development, our new identity reflects the innovation, ambition, and scientific rigor driving us forward.”

The company based in Westlake Village, California is currently in the process of developing a new drug called ‘AQR-008’.

The medication is specifically designed to tackle high cholesterol, which remains a significant factor in heart attacks and strokes.

 

Source: Aqur